ROBERT I. TABER, PH.D. - Corporate Board Profile

PALATIN TECHNOLOGIES INC

Filing Date	Source Excerpt
2001-10-26	Robert I. Taber, Ph.D. has been a director since May 2001... The audit committee is composed of Mr. deVeer, Mr. Flannery and Dr. Taber.
2002-10-28	Robert I. Taber, Ph.D. has been a director since May 2001. Dr. Taber began his career in the pharmaceutical industry in 1962, holding a succession of positions within Schering Corporations biological research group before leaving in 1982 as director of biological research. He has also held a number of increasingly important positions with DuPont Pharmaceuticals and the DuPont Merck Pharmaceutical Company, including director of pharmaceutical research, director of pharmaceutical and biotechnology research, vice president of pharmaceutical research and vice president of extramural research and development. From 1994 to 1998, Dr. Taber held the position of senior vice president of research and development at Synaptic Pharmaceuticals Corporation before founding Message Pharmaceuticals, Inc. in 1998. He is currently a director of Message Pharmaceuticals, and serves on the scientific advisory board of Locus Discovery, Inc. Dr. Taber earned his Ph.D. in pharmacology from the Medical College of Virginia. Robert I. Taber, Ph.D., director. He is a member of the audit committee.
2003-11-14	Robert I. Taber, Ph.D. has been a director since May 2001... He is a member of the audit committee and compensation committee.
2004-07-29	During the fiscal year ended June 30, 2004, Dr. Taber served on the compensation committee.
2004-10-28	Robert I. Taber, Ph.D. has been a director since May 2001. Dr. Taber began his career in the pharmaceutical industry in 1962.
2005-05-04	Dr. Taber served on the compensation committee during fiscal year ended June 30, 2004.
2005-10-28	Robert I. Taber, Ph.D. has been a director since May 2001. Dr. Taber began his career in the pharmaceutical industry in 1962, holding a succession of positions within Schering Corporations biological research group before leaving in 1982 as director of biological research. He has also held a number of increasingly important positions with DuPont Pharmaceuticals and the DuPont Merck Pharmaceutical Company, including director of pharmaceutical research, director of pharmaceutical and biotechnology research, vice president of pharmaceutical research and vice president of extramural research and development. From 1994 to 1998, Dr. Taber held the position of senior vice president of research and development at Synaptic Pharmaceuticals Corporation before founding Message Pharmaceuticals, Inc. in 1998. Dr. Taber earned his Ph.D. in pharmacology from the Medical College of Virginia.
2006-10-30	Robert I. Taber, Ph.D. has been a director since May 2001. Dr. Taber began his career in the pharmaceutical industry in 1962, holding a succession of positions within Schering Corporation's biological research group before leaving in 1982 as director of biological research. He is a member of the audit committee and compensation committee.
2007-10-29	Robert I. Taber, Ph.D. has been a director since May 2001. Dr. Taber began his career in the pharmaceutical industry in 1962, holding a succession of positions within Schering Corporation's biological research group before leaving in 1982 as director of biological research.
2009-03-31	Robert I. Taber, Ph.D. has been a director since May 2001. He is a member of the audit committee and compensation committee.
2010-04-07	Robert I. Taber, Ph.D. has been a director since May 2001. Dr. Taber began his career in the pharmaceutical industry in 1962, holding a succession of positions within Schering Corporation’s biological research group before leaving in 1982 as director of biological research. He has also held a number of increasingly important positions with DuPont Pharmaceuticals and the DuPont Merck Pharmaceutical Company, including director of pharmaceutical research, director of pharmaceutical and biotechnology research, vice president of pharmaceutical research and vice president of extramural research and development. From 1994 to 1998, Dr. Taber held the position of senior vice president of research and development at Synaptic Pharmaceuticals Corporation before founding Message Pharmaceuticals, Inc. in 1998, serving as president and chief executive officer until 2000. Dr. Taber earned his Ph.D. in pharmacology from the Medical College of Virginia. He is a member of the audit committee and compensation committee.
2011-04-05	Robert I. Taber, Ph.D. has been a director since May 2001. ... (1)Member of the Audit Committee. (2) Member of the Compensation Committee. ... The Audit Committee is composed of three non-employee directors, Mr. deVeer, Dr. Horovitz and Dr. Taber. ... The Compensation Committee is composed of Mr. deVeer, Dr. Horovitz and Dr. Taber.
2012-04-20	Robert I. Taber, Ph.D., has been a director since May 2001... Member of the Audit Committee and Compensation Committee. Total compensation: $93,822.
2012-07-31	Robert I. Taber, Ph.D. listed as a director in the beneficial ownership table
2013-05-15	Robert I. Taber, Ph.D. has been a director since May 2001. He is a member of the audit committee and the compensation committee. For our 2012 fiscal year, Dr. Taber received an annual retainer of $42,000.
2014-05-06	Robert I. Taber, Ph.D. has been a director since May 2001... Member of the audit committee and compensation committee... Director compensation table shows total compensation of $67,964.